The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,556.00
Bid: 12,588.00
Ask: 12,590.00
Change: -34.00 (-0.27%)
Spread: 2.00 (0.016%)
Open: 12,626.00
High: 12,646.00
Low: 12,474.00
Prev. Close: 12,590.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Cantor Upgrades easyJet To Buy From Hold

Tue, 09th Aug 2016 08:33

LONDON (Alliance News) - The following shares received analyst recommendations Tuesday morning and Monday:
----------
FTSE 100
----------
CANTOR FITZGERALD RAISES EASYJET TO 'BUY' ('HOLD') - TARGET 1300 PENCE
----------
TRADERS: MACQUARIE CUTS AVIVA TO 'NEUTRAL' ('OUTPERFORM')
----------
GOLDMAN CUTS AVIVA PRICE TARGET TO 480 (485) PENCE - 'BUY'
----------
BERENBERG RAISES RSA INSURANCE PRICE TARGET TO 501 (448) PENCE - 'HOLD'
----------
CITIGROUP REVISES STANDARD CHARTERED PRICE TARGET TO 750 PENCE - 'BUY'
----------
GOLDMAN RAISES STANDARD CHARTERED PRICE TARGET TO 760 (740) PENCE - 'BUY'
----------
CITIGROUP RAISES HSBC PRICE TARGET TO 600 (515) PENCE - 'BUY'
----------
GOLDMAN RAISES RBS PRICE TARGET TO 240 (235) PENCE - 'BUY'
----------
GOLDMAN CUTS LLOYDS PRICE TARGET TO 53 (55) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES BARCLAYS PRICE TARGET TO 175 (170) PENCE - 'NEUTRAL'
----------
TRADERS: NUMIS CUTS INFORMA TO 'ADD' ('BUY')
----------
RBC RAISES ANTOFAGASTA PRICE TARGET TO 500 (410) PENCE - 'SECTOR PERFORM'
----------
DEUTSCHE BANK RAISES BUNZL PRICE TARGET TO 2520 (2100) PENCE - 'BUY'
----------
JPMORGAN RAISES ASTRAZENECA PRICE TARGET TO 4900 (4800) PENCE - 'NEUTRAL'
----------
CREDIT SUISSE RAISES RELX PRICE TARGET TO 1370 (1210) PENCE - 'NEUTRAL'
----------
FTSE 250
----------
LIBERUM CUTS SERCO GROUP TO 'HOLD' ('BUY') - TARGET 135 (120) PENCE
----------
RBC RAISES INDIVIOR PRICE TARGET TO 325 (185) PENCE - 'SECTOR PERFORM'
----------
GOLDMAN RAISES WILLIAM HILL PRICE TARGET TO 320 (310) PENCE - 'NEUTRAL'
----------
DEUTSCHE BANK CUTS WILLIAM HILL PRICE TARGET TO 390 (420) PENCE - 'BUY'
----------
DEUTSCHE BANK RAISES LADBROKES PRICE TARGET TO 148 (136) PENCE - 'HOLD'
----------
SHORE CAPITAL RAISES OCADO TO 'HOLD' ('SELL')
----------
JPMORGAN CUTS JLT GROUP PRICE TARGET TO 850 (1020) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES MEGGITT PRICE TARGET TO 445 (395) PENCE - 'NEUTRAL'
----------
CITIGROUP RAISES JD WETHERSPOON PRICE TARGET TO 980 (840) PENCE - 'BUY'
----------
CREDIT SUISSE RAISES RENTOKIL INITIAL PT TO 235 (225) PENCE - 'OUTPERFORM'
----------
TRADERS: MACQUARIE RAISES PARAGON GROUP TO 'OUTPERFORM' ('NEUTRAL')
----------
GOLDMAN RAISES VEDANTA RESOURCES PRICE TARGET TO 440 (425) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES METRO BANK PRICE TARGET TO 1630 (1560) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES BBA AVIATION PRICE TARGET TO 285 (186) PENCE - 'NEUTRAL'
----------
MAIN MARKET AND AIM
----------
LIBERUM RAISES BOOHOO PRICE TARGET TO 90 (80) PENCE - 'BUY'
----------
TRADERS: NUMIS RAISES SDL TO 'ADD' ('HOLD')
----------
TRADERS: NUMIS RAISES DEVRO TO 'BUY' ('ADD')
----------
BERENBERG CUTS MOTHERCARE PRICE TARGET TO 100 (130) PENCE - 'SELL'
----------
BERENBERG CUTS CARPETRIGHT PRICE TARGET TO 230 (450) PENCE - 'HOLD'
----------
BERENBERG CUTS TOPPS TILES PRICE TARGET TO 125 (155) PENCE - 'HOLD'
----------
PANMURE RAISES GEMFIELDS RESOURCES PRICE TARGET TO 61 (57) PENCE - 'BUY'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
1 Dec 2023 08:52

LONDON MARKET OPEN: Miners give FTSE 100 boost thanks to China PMI

(Alliance News) - Stock prices in London opened higher on Friday, with the FTSE 100 boosted by mining stocks.

Read more
1 Dec 2023 08:33

AstraZeneca discontinues two phase III evidence trials for Lokelma

(Alliance News) - AstraZeneca on Friday said it has decided to discontinue the Stabilize-CKD and Dialize-outcomes phase III trials for Lokelma, citing increased enrolment timelines.

Read more
1 Dec 2023 08:01

AstraZeneca calls off two phase III trials into hyperkalaemia treatment

(Sharecast News) - Drugmaker AstraZeneca has called off two phase III trials on its hyperkalaemia treatment after a series of logistical challenges.

Read more
1 Dec 2023 07:41

LONDON BRIEFING: Stocks called higher; UK house prices fall annually

(Alliance News) - Stocks in London are called to open higher on Friday, following data from Nationwide showing that the annual pace of UK house price decline slowed in November.

Read more
27 Nov 2023 16:12

London close: Stocks start week in subdued state

(Sharecast News) - London's financial markets saw a somewhat subdued performance on Monday, as concerns regarding the Chinese economy cast a shadow over investor sentiment.

Read more
27 Nov 2023 09:20

LONDON BROKER RATINGS: Peel, Numis up Rightmove; Goldman cuts Entain

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
23 Nov 2023 18:41

IN BRIEF: AstraZeneca Chair Demare buys shares for over GBP200,000

AstraZeneca PLC - Cambridge-based pharmaceutical company - Chair Michel Demare buys 2,000 shares in total on Wednesday and Tuesday. Buys 1,000 shares for GBP101.05 each on Tuesday and 1,000 shares for GBP101.70 each on Thursday, for a total of GBP202,752.

Read more
20 Nov 2023 10:49

AstraZeneca launches new life sciences tech innovation firm Evinova

(Alliance News) - AstraZeneca PLC on Monday launched Evinova, a new health technology business focused on accelerating innovation across the life sciences sector, delivery of clinical trials and better health outcomes.

Read more
17 Nov 2023 15:20

London close: Stocks higher despite weaker retail sales data

(Sharecast News) - London's stock markets finished in a positive state on Friday despite weaker-than-expected UK retail sales figures.

Read more
17 Nov 2023 12:00

LONDON MARKET MIDDAY: Stocks shrug off downbeat UK retail sales

(Alliance News) - Stock prices in London were up at midday on Friday, as a week of favourable data as far as inflation goes gave investors a reason to overlook disappointing UK retail sales figures.

Read more
17 Nov 2023 09:03

LONDON MARKET OPEN: Stocks up despite UK retail sales growth miss

(Alliance News) - Stock prices in London opened higher on Friday, despite weaker-than-expected October retail sales figures for the UK.

Read more
17 Nov 2023 08:31

TOP NEWS: US approves AstraZeneca's Truqap for form of breast cancer

(Alliance News) - AstraZeneca PLC on Friday said that the US Food & Drug Administration approved its drug Truqap in combination with Faslodex to treat patients with an advanced form of breast cancer.

Read more
17 Nov 2023 07:58

LONDON BRIEFING: UK retail sales fall; AstraZeneca gets US approval

(Alliance News) - Stock prices in London are still set to open higher on Friday, despite October retail sales figures for the UK disappointing shortly before the opening bell.

Read more
17 Nov 2023 07:16

AstraZeneca gets US approval for breast cancer treatment

(Sharecast News) - AstraZeneca's 'Truqap', or capivasertib, in combination with 'Faslodex', or fulvestrant, has secured approval from the US Food and Drug Administration (FDA) for specific breast cancer treatments, the company announced on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.